Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tamada

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer Letters|March 23, 2020
Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancerYuji Takeyama, Minoru Kato, Satoshi Tamada, et al.
BJU International|June 5, 2014
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptidesHidenori Kawashima, Aiko Obayashi, Marie Kawamura, et al.
International Journal of Clinical Oncology|October 25, 2014
Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinomaMasahiro Nozawa, Takayuki Ohzeki, Satoshi Tamada, et al.
Urology Case Reports|January 22, 2016
A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus BevacizumabTomohiro Kanamaru, Taro Iguchi, Nao Yukimatsu, et al.
International Journal of Molecular Medicine|December 5, 2003
Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failureToshiyuki Komiya, Katsuyuki Miura, Jin Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2014
Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosingTomoaki Tanaka, Katsuyuki Kuratsukuri, Rikio Yoshimura, et al.
Transplantation|October 5, 2002
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanismToshihiro Asai, Tatsuya Nakatani, Shinya Yamanaka, et al.
Cancer Science|July 11, 2017
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cellsKazuaki Kita, Masayuki Shiota, Masako Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2026
Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open-Label Phase 2 StudyFumiya Hongo, Yasutomo Nakai, Masahiro Nozawa, et al.
Journal of Pharmacological Sciences|January 7, 2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosisSatoshi Tamada, Toshihiro Asai, Nobuyuki Kuwabara, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer Letters|March 23, 2020
Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancerYuji Takeyama, Minoru Kato, Satoshi Tamada, et al.
BJU International|June 5, 2014
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptidesHidenori Kawashima, Aiko Obayashi, Marie Kawamura, et al.
International Journal of Clinical Oncology|October 25, 2014
Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinomaMasahiro Nozawa, Takayuki Ohzeki, Satoshi Tamada, et al.
Urology Case Reports|January 22, 2016
A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus BevacizumabTomohiro Kanamaru, Taro Iguchi, Nao Yukimatsu, et al.
International Journal of Molecular Medicine|December 5, 2003
Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failureToshiyuki Komiya, Katsuyuki Miura, Jin Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2014
Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosingTomoaki Tanaka, Katsuyuki Kuratsukuri, Rikio Yoshimura, et al.
Transplantation|October 5, 2002
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanismToshihiro Asai, Tatsuya Nakatani, Shinya Yamanaka, et al.
Cancer Science|July 11, 2017
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cellsKazuaki Kita, Masayuki Shiota, Masako Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2026
Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open-Label Phase 2 StudyFumiya Hongo, Yasutomo Nakai, Masahiro Nozawa, et al.
Journal of Pharmacological Sciences|January 7, 2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosisSatoshi Tamada, Toshihiro Asai, Nobuyuki Kuwabara, et al.
Pageof 7